4//SEC Filing
PHARMACYCLICS INC 4
Accession 0001209191-15-047683
CIK 0000949699operating
Filed
May 27, 8:00 PM ET
Accepted
May 28, 6:39 PM ET
Size
12.2 KB
Accession
0001209191-15-047683
Insider Transaction Report
Form 4
Tan Heow
SVP Global Mfg & Technical Ops
Transactions
- Disposition to Issuer
Common Stock (Right to Buy)
2015-05-26−67,912→ 0 totalExercise: $27.05Exp: 2022-05-07→ Common Stock (67,912 underlying) - Disposition from Tender
Common Stock
2015-05-26$261.25/sh−11,721$3,062,111→ 0 total - Disposition to Issuer
Common Stock (Right to Buy)
2015-05-26−50,000→ 0 totalExercise: $61.60Exp: 2022-10-26→ Common Stock (50,000 underlying) - Disposition to Issuer
Common Stock (Right to Buy)
2015-05-26−30,000→ 0 totalExercise: $102.22Exp: 2024-04-02→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]Includes 259 shares acquired under the Pharmacyclics, Inc. Employee Stock Purchase Plan on April 30, 2015.
- [F2]Price reflects aggregate per share consideration paid pursuant to the Tender Offer.
- [F3]Pursuant to terms of the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie this option was cancelled in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.
Documents
Issuer
PHARMACYCLICS INC
CIK 0000949699
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000949699
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 6:39 PM ET
- Size
- 12.2 KB